Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Ron Harvey who wrote (2783)	6/10/1998 11:09:00 PM
From: Irish	Respond to of 5736

Ron: I don't know you stay so sharp late at night. Thanks for all your information to-day.You are really helping here... Regards Irish

To: Ron Harvey who wrote (2783)	6/10/1998 11:17:00 PM
From: R. M. Rosenthal	Respond to of 5736

You are entirely correct,sir. I have taken the liberty of forwarding your comments to my new friends at SEC Enforcement: Messrs. Stark, Pearlman and Goldstein at enforcement@sec.gov. I'm sure they'll be delighted to hear from other concerned shareholders as to just what's going on here. Thanks.

To: Ron Harvey who wrote (2783)	6/10/1998 11:24:00 PM
From: Quad Sevens	Read Replies (1) \| Respond to of 5736

<< 4.0 Device Description The Colormate III (Colormate III or CM III) is a computer assisted noninvasive transcutaneous bilirubinometer which, through colorimetric technology, illuminates the skin of newborn babies and measures the yellow content of the skin color. The incremental changes of these color readings measured over time are compared to the newborn's baseline readings. These data are then automatically processed to provide a numerical index of estimated bilirubin count in mg/dl that has been shown to correlate with total serum bilirubin within a clinically useful range. The Colormate III, like other colorimeters, generates a set of tristimulus color coordinates for each measurement. It then performs a series of algorithms to produce final measurement results. >> That's from the FDA approval report. Asensio claims that the CIII, with its computer algorithms, is no better than the device from the 50s, which is a series of painted stripes that a physician compares, with his/her own eyes, to the skin of a newborn. The FDA report showed the CIII decisively stomps on visual methods of assessment; they probably used the stripey painted gadget for this comparison. Asensio is lying through his teeth here. How did CIII do against blood serum bilirubin tests? << In conclusion, the Colormate III performance was superior to visual examination in estimating the true level of serum bilirubin, in addition to an excellent correlation to serum bilirubin throughout a clinically useful range. >> Wade